The CHINA Coronavirus Experimental Drug Remdesivir. Remdesivir: George Soros & Bill Gates Partner with China on Coronavirus Drug!
$4,500 or $10? Manufacturer of COVID Drug Has Big Decision
All eyes on Gilead Sciences, manufacturer of The CHINA Coronavirus Experimental Drug Remdesivir.
As drug manufacturers speed up their efforts to find a new treatment drug for the coronavirus outbreak that has devastated China and has caused a worldwide panic, a Chinese drug company just announced that it has started mass-producing an experimental drug from Gilead Sciences that has the potential to fight the novel coronavirus (1).
BrightGene Bio-Medical Technology, a Suzhou based company (2), just announced that it has developed the technology to synthesize the active pharmaceutical ingredients of Remdesivir, the drug developed by Gilead Biosciences. Its stock price surged 20% in Tuesday morning trading in Shanghai (1).
And who exactly is Gilead Biosciences? Gilead is partnered with Wuxi Pharmaceuticals (Wuxi AppTec) owned by New World Order philanthropist and mass manipulator himself, George Soros (6)(7)! Here is a printout of Soros Fund Management Portfolio which will confirm this (8)!
Wuxi Pharmaceuticals is conveniently located in the epicenter of the outbreak near Wuhan Institute of Virology that has been implicated as the Bioweapons manufacturer of this coronavirus (10)(11)(12)! Looks like China has both the Bioweapon and the cure! And let’s not forget the patent on the treatment drug! How charitable do you suppose China will be with the west?
But this story doesn’t end here. George Soros also owns Gilead Biosciences (15).
One billionaire investor behind UNITAID is George Soros himself (29). But why stop there? UNITAID is also financed by the Bill and Melinda Gates Foundation and also involves a partnership with the Clinton Health Access Initiative (CHAI) (30)(31). And interestingly enough both UNITAID and Gilead Biosciences supported Hillary Clinton for president in 2016 (32)(33).
UNITAID’s objectives are to exclude high and middle-income countries from “drug pool” while allowing “developing” countries to benefit from lower drug prices (35). In 2009 UNITAID’s board voted to exclude China and other more lucrative nations when considering targeted nations outside of Africa. However, since then all that has changed and UNITAID has now included China in its “drug pool” (36).
No comments:
Post a Comment